ULBI - Ultralife Corp Stock Price, Fair Value and News

8.73USD-0.08 (-0.91%)Market Closed

Market Summary

USD8.73-0.08

Market Closed

-0.91%

ULBI Stock Price

View Fullscreen

ULBI RSI Chart

ULBI Valuation

Market Cap

144.9M

Price/Earnings (Trailing)

20.13

Price/Sales (Trailing)

0.91

EV/EBITDA

11.22

Price/Free Cashflow

-232.58

ULBI Price/Sales (Trailing)

ULBI Profitability

Operating Margin

24.71%

EBT Margin

5.75%

Return on Equity

5.74%

Return on Assets

4.04%

Free Cashflow Yield

-0.43%

ULBI Fundamentals

ULBI Revenue

Revenue (TTM)

158.6M

Rev. Growth (Yr)

23.38%

Rev. Growth (Qtr)

12.81%

ULBI Earnings

Earnings (TTM)

7.2M

Earnings Growth (Yr)

1.4K%

Earnings Growth (Qtr)

116.02%

Breaking Down ULBI Revenue

Last 7 days

-1.9%

Last 30 days

-4.0%

Last 90 days

23.1%

Trailing 12 Months

116.6%

How does ULBI drawdown profile look like?

ULBI Financial Health

Current Ratio

3.8

Debt/Equity

0.19

Debt/Cashflow

0.08

ULBI Investor Care

Shares Dilution (1Y)

1.93%

Diluted EPS (TTM)

0.14

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	133.4M	143.9M	150.2M	158.6M
2022	102.7M	108.0M	119.5M	131.8M
2021	107.9M	106.1M	103.5M	98.3M
2020	113.7M	112.9M	109.8M	107.7M
2019	83.0M	89.5M	96.7M	106.8M
2018	86.6M	89.5M	88.8M	87.2M
2017	83.7M	83.2M	84.6M	85.5M
2016	78.1M	79.5M	80.1M	82.5M
2015	70.4M	74.1M	77.1M	76.4M
2014	73.1M	71.0M	66.7M	66.5M
2013	95.2M	93.7M	87.9M	78.8M
2012	135.3M	110.9M	101.9M	101.7M
2011	158.3M	167.7M	152.1M	135.7M
2010	0	158.5M	162.6M	166.8M
2009	0	0	0	154.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Ultralife Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 13, 2024	manna michael edward	bought	8,600	8.6	1,000	president and ceo
Dec 27, 2023	manna michael edward	acquired	26,841	5.3057	5,059	president and ceo
Dec 08, 2023	whitmore bradford t	bought	50,339	7.1913	7,000	-
Dec 06, 2023	whitmore bradford t	bought	60,604	6.8271	8,877	-
Nov 29, 2023	whitmore bradford t	bought	78,841	7.3409	10,740	-
Nov 28, 2023	whitmore bradford t	bought	79,027	7.0813	11,160	-
Nov 27, 2023	whitmore bradford t	bought	22,782	7.1196	3,200	-
Nov 10, 2023	manna michael edward	bought	3,715	7.43	500	president and ceo
Nov 01, 2023	whitmore bradford t	bought	8,266	7.5146	1,100	-
Oct 31, 2023	whitmore bradford t	bought	19,160	7.3693	2,600	-

Which funds bought or sold ULBI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 09, 2024	Rise Advisors, LLC	unchanged	-	199	881	-%
Apr 05, 2024	GAMMA Investing LLC	unchanged	-	106	537	-%
Apr 05, 2024	CWM, LLC	added	2,066	3,000	3,000	-%
Mar 21, 2024	HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	added	309	67,252	103,364	-%
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	-1,497,050	3,472,740	-%
Feb 26, 2024	Virtu Financial LLC	new	-	72,000	72,000	0.01%
Feb 15, 2024	BARCLAYS PLC	added	89.3	40,000	167,000	-%
Feb 15, 2024	JANE STREET GROUP, LLC	reduced	-24.65	-91,541	101,795	-%
Feb 14, 2024	CITADEL ADVISORS LLC	added	134	99,955	256,418	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	added	148	156,505	368,785	-%

Are Funds Buying or Selling ULBI?

Are funds buying ULBI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ULBI

No. of Funds

Unveiling Ultralife Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	visionary wealth advisors	6.62%	1,082,246	SC 13G
Feb 09, 2024	dimensional fund advisors lp	5.7%	931,030	SC 13G/A
Feb 14, 2023	visionary wealth advisors	6.39%	1,030,135	SC 13G
Feb 10, 2023	dimensional fund advisors lp	6.3%	1,010,647	SC 13G/A
Feb 15, 2022	visionary wealth advisors	5.61%	901,535	SC 13G
Feb 08, 2022	dimensional fund advisors lp	6.7%	1,070,696	SC 13G/A
Feb 17, 2021	visionary wealth advisors	5.39%	860,235	SC 13G
Feb 16, 2021	dimensional fund advisors lp	6.9%	1,097,073	SC 13G/A
Nov 06, 2020	whitmore bradford t	3.3%	518,616	SC 13D/A
Feb 18, 2020	visionary wealth advisors	5.18%	215,042	SC 13G

Recent SEC filings of Ultralife Corp

View All Filings

Date Filed	Form Type	Document
Mar 29, 2024	S-3	S-3
Mar 21, 2024	10-K	Annual Report
Mar 13, 2024	4	Insider Trading
Feb 15, 2024	8-K	Current Report
Feb 14, 2024	SC 13G	Major Ownership Report
Feb 09, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Ultralife Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
CARR	47.9B	22.1B	-8.74%	18.65%	33.3	2.17	8.21%	-59.82%
BLDR	22.2B	17.1B	-8.63%	92.98%	14.43	1.3	-24.77%	-43.97%
HUBB	21.0B	5.4B	-1.07%	69.07%	27.7	3.92	8.59%	39.18%
CSL	17.5B	4.8B	-1.30%	66.48%	22.87	3.63	-14.85%	-16.95%
LECO	13.6B	4.2B	-5.24%	48.97%	24.89	3.24	11.44%	15.46%
MID-CAP
AYI	7.6B	3.9B	-6.29%	52.06%	20.13	1.97	-6.35%	-0.40%
AAON	7.0B	1.2B	0.19%	30.43%	39.15	5.95	31.47%	76.96%
ATKR	6.3B	3.5B	-5.04%	27.89%	9.61	1.81	-10.84%	-25.77%
AEIS	3.4B	1.7B	-4.18%	2.66%	26.42	2.05	-10.27%	-35.75%
PLUG	1.9B	891.3M	-16.31%	-69.78%	-1.36	2.09	27.07%	-89.06%
SMALL-CAP
APOG	1.3B	1.4B	2.84%	35.76%	12.7	0.94	-1.78%	53.96%
ACTG	483.5M	130.3M	-4.16%	27.37%	7.21	3.71	54.06%	153.62%
ACCO	461.4M	1.8B	-8.82%	-2.99%	-21.16	0.25	-5.89%	-65.15%
FCEL	420.2M	103.0M	-12.26%	-56.54%	-4.6	4.08	-24.12%	24.29%
APT	68.8M	61.2M	2.71%	50.37%	16.42	1.12	-1.21%	27.64%

Ultralife Corp News

Latest updates

Ultralife Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	12.8%	44,548	39,488	42,692	31,916	36,107	33,234	32,126	30,373	23,763	21,761	26,770	25,973	28,976	24,362	28,560	25,814	31,023	27,493	29,397	18,882	20,927
Cost Of Revenue	11.6%	33,146	29,714	32,104	24,480	28,026	26,519	24,480	23,415	18,474	16,653	19,503	18,995	21,625	17,851	20,597	18,480	21,668	19,632	20,532	13,798	15,217
Gross Profit	16.7%	11,402	9,774	10,588	7,436	8,081	6,715	7,646	6,958	5,289	5,108	7,267	6,978	7,351	6,511	7,963	7,334	9,355	7,861	8,865	5,084	5,710
Operating Expenses	1.5%	7,753	7,639	6,923	7,410	7,864	7,301	6,853	7,253	6,518	5,887	6,176	6,026	6,136	5,804	5,669	5,849	6,883	6,555	5,823	4,536	4,643
S&GA Expenses	2.3%	5,901	5,770	5,145	5,378	6,208	5,405	5,181	5,396	4,915	4,164	4,323	4,379	4,618	4,198	4,394	4,301	4,730	4,526	4,236	3,500	3,553
R&D Expenses	-0.9%	1,852	1,869	1,778	2,032	1,656	1,896	1,672	1,857	1,603	1,723	1,853	1,647	1,518	1,606	1,275	1,548	2,153	2,029	1,587	1,036	1,091
EBITDA Margin	29.4%	0.08*	0.06*	0.05*	0.03*	0.03*	0.02*	0.01*	0.02*	0.03*	0.07*	0.08*	0.09*	0.09*	-	-	-	-	-	-	-	-
Income Taxes	-41.0%	263	446	1,375	-133	-155	-90.00	170	-251	-211	-175	248	217	682	192	499	319	515	225	676	41.00	-18,605
Earnings Before Taxes	78.0%	3,113	1,749	4,723	-468	-380	-332	678	-412	-1,339	-778	1,070	896	2,799	654	2,177	1,393	2,176	1,146	2,959	490	1,152
EBT Margin	53.5%	0.06*	0.04*	0.02*	0.00*	0.00*	-0.01*	-0.02*	-0.01*	0.00*	0.04*	0.05*	0.06*	0.07*	-	-	-	-	-	-	-	-
Net Income	116.0%	2,873	1,330	3,340	-346	-224	-239	512	-168	-1,131	-585	811	671	2,108	407	1,658	1,059	1,626	898	2,256	425	19,745
Net Income Margin	66.2%	0.05*	0.03*	0.02*	0.00*	0.00*	-0.01*	-0.01*	-0.01*	0.00*	0.03*	0.04*	0.04*	0.05*	-	-	-	-	-	-	-	-
Free Cashflow	200.3%	1,427	-1,423	1,235	-1,862	2,281	-1,238	-392	-3,593	-4,627	408	2,316	3,414	-970	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	1.2%	178	176	175	171	168	168	162	161	160	137	137	136	138	136	138	146	145	143	142	121	121
Current Assets	0.7%	90.00	90.00	88.00	81.00	79.00	79.00	72.00	69.00	67.00	65.00	64.00	64.00	64.00	62.00	65.00	74.00	70.00	69.00	69.00	65.00	67.00
Cash Equivalents	10.5%	10.00	9.00	8.00	6.00	6.00	5.00	5.00	6.00	8.00	16.00	16.00	14.00	11.00	14.00	8.00	6.00	7.00	7.00	7.00	21.00	26.00
Inventory	-9.5%	42.00	47.00	46.00	47.00	41.00	41.00	39.00	36.00	33.00	28.00	27.00	28.00	28.00	30.00	28.00	29.00	30.00	32.00	34.00	28.00	23.00
Net PPE	-0.2%	21.00	21.00	21.00	21.00	22.00	22.00	22.00	22.00	23.00	23.00	23.00	23.00	23.00	23.00	23.00	22.00	23.00	23.00	22.00	12.00	11.00
Goodwill	0.6%	38.00	37.00	38.00	38.00	37.00	37.00	38.00	38.00	38.00	27.00	27.00	27.00	27.00	27.00	26.00	26.00	27.00	26.00	27.00	20.00	20.00
Liabilities	-2.8%	53.00	54.00	56.00	55.00	52.00	53.00	45.00	44.00	42.00	18.00	17.00	19.00	21.00	22.00	25.00	36.00	35.00	36.00	36.00	17.00	16.00
Current Liabilities	-10.1%	24.00	26.00	29.00	29.00	29.00	28.00	22.00	20.00	19.00	17.00	16.00	17.00	19.00	17.00	14.00	19.00	17.00	18.00	20.00	16.00	15.00
Long Term Debt	-2.0%	24.00	24.00	23.00	21.00	19.00	21.00	20.00	20.00	19.00	-	-	-	-	2.00	9.00	15.00	16.00	16.00	14.00	-	-
LT Debt, Current	0%	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	0.00	1.00	1.00	1.00	2.00	1.00	1.00	1.00	1.00	1.00	-	-
LT Debt, Non Current	-2.0%	24.00	24.00	23.00	21.00	19.00	21.00	20.00	20.00	19.00	-	-	-	-	2.00	9.00	15.00	16.00	16.00	14.00	-	-
Shareholder's Equity	3.0%	125	122	120	116	116	115	117	118	118	119	119	118	117	114	112	110	110	107	106	104	104
Retained Earnings	6.6%	-40.75	-43.63	-44.96	-48.30	-47.95	-47.73	-47.49	-48.00	-47.83	-46.70	-46.12	-46.93	-47.60	-49.71	-50.11	-51.77	-52.83	-54.46	-55.35	-57.61	-58.03
Additional Paid-In Capital	0.2%	189	189	188	188	187	187	187	187	187	186	186	186	185	185	185	185	184	184	183	183	183
Shares Outstanding	-0.6%	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	-	-	-	-	-	-	-	-	-
Minority Interest	-19.5%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.03	-0.06	-0.08
Float	-	-	-	47.00	-	-	-	44.00	-	-	-	83.00	-	-	-	69.00	-	-	-	78.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	373.6%	2,432	-889	1,751	-1,365	2,564	-427	-178	-3,222	-4,137	1,507	3,052	3,903	229	12,609	9,247	-365	1,877	-601	-3,701	-545	3,355
Share Based Compensation	-20.6%	104	131	154	139	224	179	184	189	159	142	186	184	187	222	304	230	377	159	175	185	183
Cashflow From Investing	-88.2%	-1,005	-534	-516	-497	-283	-811	-214	-371	-24,009	-1,099	-736	-489	-1,199	-369	-968	-445	-1,435	-1,053	-26,460	-2,581	-2,191
Cashflow From Financing	-112.4%	-301	2,429	1,562	1,800	-1,579	1,303	-429	1,223	20,578	-394	-122	-420	-2,436	-6,909	-6,027	-322	-379	2,177	15,935	-1,609	-586
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,957	-

ULBI Income Statement

2023-12-31

Consolidated Statements of Loss and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenues	$ 158,644	$ 131,840
Cost of products sold	119,444	102,440
Gross profit	39,200	29,400
Operating expenses:
Research and development	7,531	7,081
Selling, general and administrative	22,194	22,190
Total operating expenses	29,725	29,271
Operating income	9,475	129
Other expense (income):
Interest and financing expense	2,016	951
Miscellaneous income	(1,658)	(376)
Total other expense, net	358	575
Loss before income taxes	9,117	(446)
Income tax (benefit) provision	1,951	(326)
Net loss	7,166	(120)
Net (loss) income attributable to non-controlling interest	(31)	(1)
Loss attributable to Ultralife Corporation	7,197	(119)
Other comprehensive (loss) income:
Foreign currency translation adjustments	90	(2,097)
Comprehensive loss attributable to Ultralife Corporation	$ 7,287	$ (2,216)
Net loss per share attributable to Ultralife Corporation common shareholders – Basic (in dollars per share)	$ 0.03	$ 0.05
Net loss per share attributable to Ultralife Corporation common shareholders – Diluted (in dollars per share)	$ 0.03	$ 0.05
Weighted average shares outstanding – Basic (in shares)	16,214	16,125
Weighted average shares outstanding – Diluted (in shares)	16,226	16,125

ULBI Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 10,278	$ 5,713
Trade accounts receivable, net of allowance for doubtful accounts of $303 and $346, respectively	31,761	27,779
Inventories, net	42,215	41,192
Prepaid expenses and other current assets	5,949	4,304
Total current assets	90,203	78,988
Property, plant and equipment, net	21,117	21,716
Goodwill	37,571	37,428
Other intangible assets, net	15,107	15,921
Deferred income taxes, net	10,567	12,069
Other noncurrent assets	3,711	2,308
Total assets	178,276	168,430
Current Liabilities:
Accounts payable	11,336	16,074
Current portion of long-term debt	2,000	2,000
Accrued compensation and related benefits	3,115	2,890
Accrued expenses and other current liabilities	7,279	7,949
Total current liabilities	23,730	28,913
Long-term debt, net	23,624	19,310
Deferred income taxes	1,714	1,917
Other noncurrent liabilities	3,781	1,887
Total liabilities	52,849	52,027
Commitments and Contingencies
Shareholders' Equity:
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued	0	0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,570,710 shares and 20,522,427 shares, respectively;outstanding – 16,135,358 shares and 16,089,832 shares, respectively	2,078	2,057
Capital in excess of par value	189,160	187,405
Accumulated deficit	(40,754)	(47,951)
Accumulated other comprehensive loss	(3,660)	(3,750)
Treasury stock - at cost; 4,435,352 shares and 4,432,595 shares, respectively	21,492	21,484
Total Ultralife Corporation equity	125,332	116,277
Non-controlling interest	95	126
Total shareholders’ equity	125,427	116,403
Total liabilities and shareholders' equity	$ 178,276	$ 168,430

About Ultralife Corp

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliquÃƒÂ© systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife Batteries, Lithium Power, McDowell Research, AMTITM, ABLETM, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, SWE SEASAFE, Excell Battery Group, and Criterion Gauge brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. The company serves government, defense, and commercial sectors. Ultralife Corporation was incorporated in 1990 and is headquartered in Newark, New York.

CEO	Mr. Michael E. Manna
WEBSITE	ultralifecorporation.com
INDUSTRY	Communication Equipment
EMPLOYEES	547

Ultralife Corp Frequently Asked Questions

What is the ticker symbol for Ultralife Corp? What does ULBI stand for in stocks?

ULBI is the stock ticker symbol of Ultralife Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ultralife Corp (ULBI)?

As of Thu Apr 18 2024, market cap of Ultralife Corp is 144.9 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ULBI stock?

You can check ULBI's fair value in chart for subscribers.

What is the fair value of ULBI stock?

You can check ULBI's fair value in chart for subscribers. The fair value of Ultralife Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Ultralife Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ULBI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Ultralife Corp a good stock to buy?

The fair value guage provides a quick view whether ULBI is over valued or under valued. Whether Ultralife Corp is cheap or expensive depends on the assumptions which impact Ultralife Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ULBI.

What is Ultralife Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, ULBI's PE ratio (Price to Earnings) is 20.13 and Price to Sales (PS) ratio is 0.91. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ULBI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Ultralife Corp's stock?

In the past 10 years, Ultralife Corp has provided 0.091 (multiply by 100 for percentage) rate of return.